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ABSTRACT
Objectives Healthcare professionals other than 
rheumatologists experience difficulties in detecting 
early inflammatory arthritis (IA) by joint examination. 
Self- reported symptoms are increasingly considered as 
helpful and could be incorporated in online tools to assist 
healthcare professionals, but first their discriminative 
ability must be assessed. As part of this effort, we 
evaluated whether inquiring about functional impairments 
could aid early IA identification.
Design Cross- sectional derivation and validation study.
Setting Data from two Early Arthritis Recognition Clinics 
(EARC) in the Netherlands were studied, which are easy 
access outpatient rheumatology clinics intermediary 
between primary and secondary care for patients in whom 
general practitioners suspect but are unsure about IA 
presence.
Participants Between 2010 and 2014, 997 patients 
consecutively visited the Leiden- EARC (derivation cohort). 
Patients consecutively visiting the Groningen EARC (2010–
2014, n=506) and Leiden- EARC (2015–2018, n=557) 
served as validation cohorts.
Primary and secondary outcome measures Physical 
functioning was assessed with the Health Assessment 
Questionnaire Disability- Index (HAQ); IA presence 
by physical joint examination by rheumatologists. 
HAQ questions were studied individually regarding 
discriminative ability for IA presence. For the best 
discriminating question, ORs and positive predictive values 
(PPVs) for IA presence were determined.
Results IA was ascertained in 43% (derivation cohort), 
53% and 35% (validation cohorts). In the derivation cohort, 
IA presence associated with higher mean HAQ scores 
(0.84 vs 0.73, p=0.003). One question on difficulties 
with dressing equalled discriminative ability of the total 
HAQ score. ‘Difficulties with dressing’ yielded ORs for 
IA presence of 1.8 (95% CI 1.4 to 2.4) in the derivation 
cohort; 2.0 (1.4 to 2.9) and 2.1 (1.5 to 3.1) in the validation 
cohorts. After adjustments for clinical characteristics these 
were 1.7 (1.3 to 2.3), 1.6 (1.1 to 2.5) and 1.9 (1.2 to 2.9). 
PPVs (probabilities of IA for positive answers) ranged 
42%–60% and negative predictive values (probabilities of 
no IA for negative answers) ranged 57%–74%.
Conclusions Patient- reported difficulties with dressing 
in patients with suspected IA associated with actual IA 
presence. Although further validation is required, for 
example, in primary care, this simple question could be 
of help in future early IA detection tools for healthcare 
professionals with limited experience in joint examination.
INTRODUCTION
In rheumatoid arthritis (RA), early initiation 
of treatment with disease- modifying anti-
rheumatic drugs is associated with improved 
outcomes.1 2 Also for other types of inflam-
matory arthritis (IA) the importance of early 
treatment is increasingly recognised.3–5 To 
achieve early treatment initiation, however, it 
is necessary for at- risk patients to be referred 
to a rheumatologist in a timely fashion.6
Consequently, general practitioners (GPs) 
play a crucial role in early identification of IA, 
but they have indicated considerable barriers 
regarding timely and adequate referral of 
patients with musculoskeletal complaints, 
Strengths and limitations of this study
 ► We evaluated the value of questions about function-
al impairments for early recognition of inflammatory 
arthritis (IA), for which new and simple tools are ur-
gently needed — especially in primary care.
 ► This was studied in a setting intermediary between 
primary and secondary care that services patients 
whose general practitioners were doubtful about the 
presence of IA; the population for whom such new 
tools are most relevant.
 ► This association was tested for independence from 
known predictors and validated in two independent 
cohorts.
 ► However, further validation in primary care is need-
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including a lack of self- confidence in detecting synovitis.7 
GPs generally have limited experience with the detection 
of IA by joint palpation compared with rheumatologists, 
since their patient population is characterised by a rela-
tively low incidence of RA and IA (0.7/1000 patient- years 
in the Netherlands, which amounts to 1–2 new patients 
on average per GP per year) compared with a much 
higher incidence of other musculoskeletal complaints.8–10 
These circumstances may add to referral delay at the level 
of the initial healthcare provider (usually the GP), which 
was found to be an important contributor to overall delay 
until treatment initiation in many European countries.11
In this light, the search for novel strategies to improve 
early recognition and referral of patients at risk for IA and 
RA remains of great importance. This was emphasised in 
the latest update of the European League against Rheu-
matism research agenda for early arthritis by including 
‘the identification of tools that could help GPs diagnose 
early arthritis and prioritise referral.’6 Given the increasing 
usage of healthcare- related mobile applications (apps),12 
new tools are preferred to be simple and time- efficient, 
providing suitability for possible future digital initiatives for 
early IA screening. In addition to ease of use, such tools 
should be based on valid and reliable data but currently 
most medical mobile apps are not properly evidence based, 
highlighting the need for thorough research.13
Patients with IA generally experience limitations in phys-
ical functioning. One could hypothesise that these limita-
tions may differ in sort and severity compared with those 
related to other, less urgent causes of joint symptoms. 
Functional impairments in patients with rheumatic diseases 
are generally assessed using the Health Assessment Ques-
tionnaire Disability Index (HAQ),14 but use of this patient- 
reported outcome instrument is mostly limited to research 
in established rheumatic disease instead of earlier stages. 
Nonetheless, it is generally considered a self- explanatory 
and relatively efficient questionnaire (it can be completed 
within 5 minutes).15 In order to search for tools that might 
facilitate early identification of IA we performed a cross- 
sectional study on the association between functional 
impairments (measured by the HAQ) and presence of 
IA at joint examination (identified by rheumatologists). 
Aiming for simple and time- efficient use in daily prac-
tice, we also studied the HAQ questions separately and 
evaluated whether a single question could facilitate early 
identification of IA. Although information on functional 
impairments alone is not expected to have sufficient accu-
racy, it may be used as part of a more comprehensive tool 
that could be incorporated in a screening app for early IA. 
Findings were verified in two validation cohorts.
PATIENTS AND METHODS
Patients
Aiming to decrease referral delay in early IA, Early Arthritis 
Recognition Clinics (EARC) were initiated in 2010 at the 
Leiden and Groningen University Medical Centres in 
the Netherlands. The EARC design has been described 
previously.16 In short, EARCs are clinics for patients in 
whom their GP suspects but is unsure about the presence 
of IA. These easy- access clinics are characterised by their 
unique intermediate setting, namely in between primary 
and secondary care. The EARCs have no waiting lists, can be 
visited by referred patients once to twice a week without an 
appointment and have markedly reduced referral delay.16 
GPs in the region are instructed to quickly refer any patient 
for whom they are unsure about the presence of IA, instead 
of applying a strategy of ‘watchful waiting’ or performing 
additional diagnostic tests. Notably, autoantibodies or other 
additional investigations are generally not performed by 
GPs in our region,17 which is in accordance with the Dutch 
national guidelines.18
At the EARC, patients completed a brief clinical ques-
tionnaire on their symptoms, followed by a short consul-
tation and full 66- joint examination by an experienced 
rheumatologist. If IA was detected at physical examination 
(by palpable joint swelling), patients were analysed at the 
regular rheumatology outpatient clinic for further diag-
nosis. Otherwise, they were referred back to their GP. Labo-
ratory tests and imaging were not performed at the EARC.
The derivation cohort comprised 997 patients who 
consecutively visited the Leiden- EARC between September 
2010 and April 2014. The first validation cohort consisted 
of 506 patients who visited the Groningen- EARC from 
September 2010 to January 2014. The second valida-
tion cohort consisted of 557 patients who visited the 
Leiden- EARC from November 2015 to December 2018. 
Patients who visited the Leiden- EARC from April 2014 
to November 2015 did not fill out questions on physical 
functioning and were not included in this study.
Patient and public involvement
Patient research partners agreed with the pathway of care 
at EARC and provided feedback on the questionnaire, 
which was expanded in 2012 with two questions.
Health Assessment Questionnaire
Physical functioning was assessed during the same EARC- 
visit using the HAQ, a questionnaire containing 20 
questions on impairments across eight functional catego-
ries.14 15 Each question was scored by patients on a 4- point 
scale ranging 0–3, representing the degree of difficul-
ties experienced when performing the corresponding 
activity, with 0 indicating no difficulties and 3 indicating 
full disability. The total HAQ score is calculated as the 
average across eight categories and ranges 0–3. Patients 
in the derivation cohort and patients in the first vali-
dation cohort filled out the full HAQ. Based on initial 
results from the derivation cohort, patients in the second 
validation cohort were asked to complete only question 
1A on difficulties with dressing.
Outcome
The outcome used in all statistical analyses was presence 
of IA, determined by the rheumatologist at physical exam-
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subsequent visit(s) at the regular rheumatology outpa-
tient clinic and were beyond the scope of this study. The 
rheumatologists who determined IA at joint examination 
were not formally blinded to the HAQ data; at request, 
however, the participating rheumatologists answered not 
to consider HAQ data in their evaluation of the presence 
of IA (personal communication).
Statistical analyses
In the derivation cohort, total HAQ scores were compared 
between patients with and without IA at joint examina-
tion. Areas under the curve (AUCs) were determined for 
the total HAQ score as well as its questions individually, 
in order to select the best discriminating question for 
further investigation (based on highest AUC). The use 
of aids and devices was taken into account for calculation 
of the total HAQ score as prescribed, but not for scores 
on individual questions.14 15 For the best discriminating 
question, ORs and AUCs were determined with both the 
original, categorical responses and with binary responses 
(no vs any degree of difficulties; i.e., scores ≥1), since a 
binary tool would be even more suited for easy use in daily 
practice. ORs were adjusted for age and gender.19–21 Test 
characteristics and probabilities of IA were calculated. 
Analyses were repeated in the two validation cohorts.
A previous study from the Leiden- EARC derived an 
algorithm for IA identification, consisting of clinical 
variables that were independently associated with the 
presence of IA (being male, age ≥60 years, symptom 
duration, acuteness of symptom onset, morning stiffness 
>60 min, number of painful joints, presence of patient- 
reported swollen joint(s) and difficulties with making 
a fist).21 These variables were included in multivariable 
logistic regression analyses, to study if self- reported func-
tional disabilities were independently associated with IA. 
In addition, change in diagnostic accuracy when adding 
functional disability to the algorithm was assessed in the 
derivation cohort by comparing AUCs.
The HAQ question of interest was missing in 4%, 2% 
and 3% of the cohorts, respectively. Characteristics of 
patients with available and missing data on this HAQ 
question were compared. Missing values were imputed 
using multiple imputation by chained equations with 
predictive mean matching.22 Rubin’s rules were applied 
to pool point estimates and CIs across 30 imputations.23 
Imputed data were used for the main analyses. In sensi-
tivity analyses, results were compared with those obtained 
from the unimputed data.
IBM SPSS (V.25) and R (V.3.5.2) were used. P 
values<0.05 were considered statistically significant.
RESULTS
Patients
Patient characteristics for all three cohorts are presented 
in table 1. Over 80% in each cohort presented with hand 
and/or wrist arthralgia. IA was diagnosed in 43%, 53% 
and 35% of patients, respectively. Patients in the first vali-
dation cohort had a slightly longer symptom duration 
Table 1 Characteristics of patients visiting the Early Arthritis Recognition Clinics
Derivation cohort 
(n=997)




Inclusion period, years 2010–2014 2010–2014 2015–2018
Male, n (%) 290 (29) 177 (35) 183 (33)
Age in years, mean±SD 51±16 52±16 54±16
Symptom duration in weeks, median (IQR) 12 (4–62) 18 (5–69) 13 (4–57)
Acute onset of symptoms, n (%) 368 (38) 187 (38) 203 (38)
Morning stiffness in minutes, median (IQR) 10 (0–30) 10 (0–31) 10 (0–30)
No. of painful joints, median (IQR) 7 (3–15) 9 (4–18) 8 (2–17)
No. of patient- reported swollen joints, median (IQR) 2 (1–5) 3 (1–8) 2 (1–5)
Difficulties with making a fist, n (%) 242 (47) 130 (54) 291 (54)
Arthralgia location, n (%)
  ≥1 hand or wrist joint 810 (81) 424 (84) 455 (82)
  ≥1 forefoot joint 254 (25) 142 (28) 152 (27)
  ≥1 hand, wrist or forefoot joint 869 (87) 454 (90) 486 (87)
  Exclusively large joints* 22 (2) 18 (4) 9 (2)
HAQ score, mean±SD 0.77±0.59 0.88±0.67 –†
IA present at joint examination, n (%) 426 (43) 267 (53) 193 (35)
Original, unimputed data.
*Shoulder, elbow, hip, knee or ankle.
†Patients in the second validation cohort did not complete the full HAQ but only the question on difficulties with dressing.
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(median 18 weeks) than patients in the derivation and 
second validation cohorts (median 12 and 13 weeks, 
respectively). All other characteristics were similar.
Discriminative ability of a single question equalled the total 
HAQ score
Patients with IA at physical examination had a higher 
mean total HAQ score than patients without IA in the 
derivation cohort (0.84 (95% CI 0.77 to 0.89) compared 
with 0.73 (0.67 to 0.77), p=0.003), indicating a higher 
degree of functional disability. A gradual increase of the 
probability of IA at joint examination was observed as 
total HAQ scores rose (figure 1A).
To search for a method that is more simple and time- 
efficient for usage in daily practice than the 20- question 
total HAQ, its questions were also studied individually 
(online supplemental table S1). Of these questions, scores 
on ‘difficulties with dressing’ (question 1A) yielded the 
highest AUC, which equalled the AUC of the total HAQ 
score: 0.58 (0.55–0.62) vs 0.55 (0.52–0.59), respectively. 
This indicates that, in addition to greater ease of use, the 
discriminative ability of just one question was equal to 
the total HAQ. For these reasons, this question (‘Are you 
able to dress yourself, including shoelaces and buttons?’) 
was considered the best discriminating question and 
was studied further instead of the total HAQ score. 
The percentage of patients with different categories of 
impairment among the patients with and without IA are 
presented in table 2. The probabilities of IA presence 
for the different categories of impairments with dressing 
are indicated in figure 1B; the probability increased with 
more impairment.
Since a binary question is even easier to implement in 
practice, we assessed the discriminative ability of dichoto-
mised scores on difficulties with dressing. Loss of overall 
discriminative ability, measured using the AUC, induced 
by dichotomisation into a binary score was minor (AUC 
of 0.57 (0.54–0.61) vs 0.58 (0.55–0.62)). Observed prob-
abilities of IA presence with this dichotomised score are 
presented in figure 1C. For the benefit of ease of use this 
minor difference was accepted and dichotomised scores 
were used in subsequent analyses.
Difficulties with dressing were independently associated with 
presence of IA in derivation cohort
ORs for the IA presence of a confirmative answer on the 
question about difficulties with dressing are presented in 
Figure 1 Observed probabilities of IA according to (A) the 
total HAQ; (B) the degree of difficulties with dressing and (C) 
the presence of difficulties with dressing.  
(A) Dot sizes vary according to the number of patients with 
that particular total HAQ score. The fit line was calculated by 
means of binary logistic regression. HAQ, Health Assessment 
Questionnaire Disability Index; IA, inflammatory arthritis.
Table 2 Association between presence of IA and the 
degree of difficulties with dressing in the derivation cohort 





No IA N 
(%*) OR (95% CI)
AUC 
(95% CI)
Categorical† 0 169 (40) 310 (54) 1.00 (ref) 0.58 
(0.55 to 
0.62)
1 188 (44) 210 (37) 1.64 (1.24 to 
2.16)
2 62 (15) 45 (8) 2.49 (1.61 to 
3.84)
3 7 (2) 6 (1) 2.20 (0.73 to 
6.66)
Binary No (0) 169 (40) 310 (54) 1.00 (ref) 0.57 
(0.54 to 
0.61)
Yes (≥1) 257 (60) 261 (46) 1.80 (1.39 to 
2.33)
Results were pooled across 30 imputations; percentages and numbers 
were rounded.
*Percentage of the total number of patients with and without IA, 
respectively.
†0=‘without any difficulty’; 1=‘with some difficulty’; 2=‘with much 
difficulty’; 3=‘unable to do’.
AUC, area under the receiver operating characteristics curve; IA, 















pen: first published as 10.1136/bm






5van Dijk B, et al. BMJ Open 2020;10:e040148. doi:10.1136/bmjopen-2020-040148
Open access
table 3. In the derivation cohort, the presence of difficul-
ties with dressing (scores ≥1) was associated with presence 
of IA with an age and gender adjusted OR of 1.83 (95% CI 
1.41 to 2.39). After further adjustment for the aforemen-
tioned clinical variables that were previously identified as 
associated with IA (being male, age ≥60 years, symptom 
duration, acuteness of symptom onset, morning stiffness 
>60 min, number of painful joints, presence of patient- 
reported swollen joint(s) and difficulties with making a 
fist), difficulties with dressing remained independently 
associated with the presence of IA, with an OR of 1.71 
(95% CI 1.27 to 2.32). ORs for the other clinical variables 
are provided in online supplemental table S2. The AUC 
of the model with only the aforementioned clinical vari-
ables was 0.72 (95% CI 0.69 to 0.76), while the model 
where difficulties with dressing was added had an AUC of 
0.73 (95% CI 0.70 to 0.77). Since the presence of difficul-
ties with dressing was independently associated with IA, it 
was subsequently studied in the validation cohorts.
Difficulties with dressing were independently associated with 
presence of IA in both validation cohorts
In the first and second validation cohorts, age and gender 
adjusted ORs were 1.89 (95% CI 1.31 to 2.72) and 1.95 
(95% CI 1.32 to 2.86), respectively. After further adjust-
ment for the aforementioned clinical variables that were 
previously identified as associated with IA, ORs were 1.64 
(95% CI 1.08 to 2.50) and 1.87 (95% CI 1.20 to 2.92), 
respectively. Thus, the independent association of diffi-
culties with dressing with presence of IA was confirmed in 
both validation cohorts.
Predictive values and test characteristics
Lastly, we studied test characteristics and predictive 
values of positive answers on just the single question 
about difficulties with dressing (figure 2). The negative 
predictive values (NPVs) in the different cohorts ranged 
between 57% and 74%, indicating that 57%–74% of 
patients without difficulties with dressing had no IA at 
physical examination. The positive predictive values 
(PPVs) ranged between 42% and 60%, meaning that 
42%–60% of patients who reported to have difficulties 
with dressing were indeed identified as having IA.
Sensitivity analyses on unimputed data
No clinically relevant differences in characteristics of 
patients with and without information on ‘difficulties 
with dressing’ were found in online supplemental table 
S3. Subanalyses limited to the unimputed data (online 
supplemental table S4) yielded similar results as in the 
main analyses.
DISCUSSION
Healthcare professionals who are not rheumatologists 
generally have limited experience in joint examination, 
which hampers them in early identification of IA. For 
GPs, this contributes to referral delay and necessitates 
the development of feasible tools that could support early 
identification of IA. We investigated the value of infor-
mation on functional impairments in a cross- sectional 
study including patients with suspected but doubtful early 
IA according to GPs. We observed that, among patients 
with suspected IA according to GPs, those with actual IA 
according to the rheumatologist had higher HAQ scores, 
and that the discriminative ability of a binary answer to 
a single question on difficulties with dressing was equal 
to that of the total HAQ. Results were validated in inde-
pendent cohorts of a similar setting, namely in between 
primary and secondary care. Together the results imply 
that easily obtainable information on functional impair-
ments may be of value in facilitating early detection of IA.
The HAQ was originally designed for patient- reported 
outcome assessment and not as a diagnostic tool.14 
However, it is the most widely used and validated instru-
ment in the field of rheumatology for measuring func-
tional impairments.15 24 The HAQ was neither designed 
to use in parts (and assess questions individually) when 
used as outcome measure. Despite these limitations, 
the current data suggest that a simple question on 
Figure 2 Test characteristics of the presence of difficulties 
with dressing (scores ≥1), with IA at physical examination as 
outcome. Results were pooled across 30 imputations. Error 
bars indicate the 95% CI. IA, inflammatory arthritis; NPV, 
negative predictive value; PPV, positive predictive value; 
Sens., sensitivity; Spec., specificity.
Table 3 Presence of difficulties with dressing associated 
with presence of IA independently from other clinical 
variables
OR (95% CI) 
univariable
OR (95% CI) age, 
gender adjusted




1.80 (1.39 to 
2.33)




2.00 (1.39 to 
2.87)





2.14 (1.48 to 
3.10)
1.95 (1.32 to 2.86) 1.87 (1.20 to 
2.92)
Results were pooled across 30 imputations.
*Adjusted for: being male, age ≥60 years, symptom duration, 
acuteness of symptom onset, morning stiffness >60 min, number 
of painful joints, presence of patient- reported swollen joint(s) and 
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difficulties with dressing, as deduced from the total HAQ, 
is of discriminative relevance. The simplicity of a single 
question and binary answers (no vs any difficulties with 
dressing) may facilitate the use of assessing functional 
impairments for diagnostic purposes in busy daily prac-
tice and as part of future internet or mobile app based 
tools for early identification of IA.
The best discriminating question was one related 
to hand function. Interestingly, over 80% of patients 
reported to have symptoms of the hands (table 1). 
Presumably, GPs are more often doubtful about IA in 
hand joints since these are relatively small joints and 
synovitis is often subtle. Alternatively, GPs may be more 
inclined to assess hand joints compared with other joints. 
Exploratory subgroup analyses limited to patients who 
indicated to have hand symptoms yielded similar results 
(data not shown).
The current study was, to the best of our knowledge, 
the first to investigate the discriminative ability of func-
tional impairments measured by the HAQ in the context 
of identifying early IA. Several other tools to promote 
detection of early IA have been reported, including self- 
administered questionnaires and internet- based tools for 
primary care providers.25–28 However, none of these were 
validated tools that incorporated patient- reported func-
tional impairments. The best studied initiative, the Early 
Inflammatory Arthritis Detection Tool reported by Bell et 
al25 contained one question on functional impairments 
in general, namely whether important activities were 
affected by joint problems. Although this tool showed 
good overall discriminative ability, it was externally vali-
dated only in a tertiary care setting.29 Its usability in cases 
of diagnostic uncertainty remains undetermined.
It is unknown how patient- reported functional impair-
ments currently influence referral policy in patients with 
suspected IA in primary care. Information on functional 
limitations is generally lacking in local guidelines and 
referral criteria.18 30–36 The Dutch GP guideline on IA, for 
example, recommends asking patients about the impact 
of their joint complaints on their daily lives, but does 
not specify the information that should be collected and 
in which way this should be incorporated into decision 
making and referral policy.18
Although we attempted to seek for evidence on simple 
methods that are helpful to identify IA, the AUC reached 
by ‘difficulties with dressing’ was fairly limited. It is not 
surprising that a single question did not perform equally 
accurate as the reference, that is, evaluation of swollen 
joints with joint palpation. However, particularly in the 
current absence of other evidence- based strategies, this 
simple question that requires almost no extra effort, time 
or resources may be of value in improving early identifi-
cation of IA.
The main strengths of the current study are related to 
the unique easy- access setting of the EARCs intermediary 
between primary and secondary care. First, the EARCs 
could be visited weekly without waiting list. Second, GPs 
in our regions were encouraged to refer any patient in 
whom they suspected but doubted about the presence of 
IA, resulting in a selection of patients in whom there is 
a lower and more uncertain suspicion of IA than would 
be the case at one of the more extensively studied Early 
Arthritis Clinics. The latter are secondary care facili-
ties intended for patients with clear presence or a very 
high suspicion of IA. Other strengths are the validation 
of our findings in two cohorts and critical evaluation of 
the added clinical relevance by adjusting for previously 
reported diagnostic variables.
A limitation of our study is that data were not collected 
in primary care practices. Given the relatively low inci-
dence of IA in primary care, it must be noted that prospec-
tive research on this subject in general practices would 
be particularly challenging and resource- intensive. Still, 
validation in primary care is the next step to be taken. 
Although the sensitivity and specificity are expected to 
remain stable across differences in prevalence of IA, PPV 
and NPVs are dependent on prior risks and may differ 
in primary care. Another limitation is that it is unknown 
how many patients were referred to but did not visit the 
EARC. Although we assumed this number to be relatively 
low because of the accessible nature of the EARCs, it may 
have influenced the prevalence of IA in the study popula-
tion. Nevertheless, the prevalence observed in this study 
suggests that GPs in our region already perform quite 
well in prioritising referrals, since their suspicion of IA 
was correct in almost half of referred patients. This is in 
line with previous findings from the EARC.16 21 Finally, 
as data were collected cross- sectionally and not longitudi-
nally, analyses were not stratified for final diagnoses and 
patients who would develop RA were not studied sepa-
rately. On the other hand, patients with other types of 
IA (eg, spondylo, psoriatic and undifferentiated arthritis) 
will most likely benefit from early treatment and referral 
to a rheumatologist as well.3–5
In conclusion, we studied the discriminative ability of 
functional limitations measured by the HAQ and indi-
vidual HAQ questions in patients with suspected early 
IA. One question on difficulties with dressing by itself 
had a discriminative ability for actual presence of IA 
that equalled the full HAQ score and was validated in 
two cohorts. Although further research in primary care 
settings is necessary, the current data illustrate that a 
binary response to the question ‘Are you able to dress 
yourself, including shoelaces and buttons?’ is helpful in 
the assessment of patients with suspected early IA and 
could be used in future internet or mobile app based 
tools aiming for early identification of IA.
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